PMC:7647877 / 71236-71587 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T824","span":{"begin":160,"end":163},"obj":"Body_part"},{"id":"T825","span":{"begin":186,"end":196},"obj":"Body_part"},{"id":"T826","span":{"begin":238,"end":248},"obj":"Body_part"}],"attributes":[{"id":"A824","pred":"fma_id","subj":"T824","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A825","pred":"fma_id","subj":"T825","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A826","pred":"fma_id","subj":"T826","obj":"http://purl.org/sig/ont/fma/fma7199"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T309","span":{"begin":88,"end":95},"obj":"Disease"}],"attributes":[{"id":"A309","pred":"mondo_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T956","span":{"begin":160,"end":163},"obj":"http://purl.obolibrary.org/obo/UBERON_0001007"},{"id":"T957","span":{"begin":160,"end":163},"obj":"http://purl.obolibrary.org/obo/UBERON_0001555"},{"id":"T958","span":{"begin":160,"end":163},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T959","span":{"begin":186,"end":196},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T960","span":{"begin":186,"end":196},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T961","span":{"begin":238,"end":248},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T962","span":{"begin":238,"end":248},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4723","span":{"begin":264,"end":272},"obj":"Chemical"},{"id":"T10343","span":{"begin":333,"end":344},"obj":"Chemical"}],"attributes":[{"id":"A99226","pred":"chebi_id","subj":"T4723","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A73109","pred":"chebi_id","subj":"T10343","obj":"http://purl.obolibrary.org/obo/CHEBI_26195"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T119","span":{"begin":88,"end":95},"obj":"Phenotype"}],"attributes":[{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T445","span":{"begin":0,"end":351},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1582","span":{"begin":333,"end":344},"obj":"Chemical"},{"id":"1584","span":{"begin":28,"end":52},"obj":"Disease"},{"id":"1585","span":{"begin":88,"end":95},"obj":"Disease"}],"attributes":[{"id":"A1582","pred":"tao:has_database_id","subj":"1582","obj":"MESH:D059808"},{"id":"A1584","pred":"tao:has_database_id","subj":"1584","obj":"MESH:D003141"},{"id":"A1585","pred":"tao:has_database_id","subj":"1585","obj":"MESH:D009765"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"As shown, the prevention of cardiometabolic diseases, considering the relationship with obesity, may be possible reducing the inflammatory state, acting on the gut-microbiota and on the intestinal permeability improving the health of the intestinal flora, with 4P medicine and treatment with probiotics, prebiotics, postbiotics, and polyphenols [166]."}